autologous CEFFE (Samei )
自体脂肪脱细胞活性蛋白（萨美细胞）
Report date: 2025/05/07 16:57:07
Base Information
Drug Nameautologous CEFFE (Samei )
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Samei Cell Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNinth People'S Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A